SRPK1: A cisplatin sensitive protein expressed in retinoblastoma

Pediatric Blood and Cancer

Volumn 50, Issue 2, 2008, Pages 402-406

  Krishnakumar, Subramanian ^a   Mohan, Adithi ^a,d   Kandalam, Mallikarjuna ^a,d   Ramkumar, Hema L ^b   Venkatesan, Nalini ^a   Das, Radha R ^c  

^a VISION RESEARCH FOUNDATION   (India)

^b NORTHWESTERN UNIVERSITY   (United States)

^c MEDICAL RESEARCH FOUNDATION   (India)

^d BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Carboplatin; Chemotherapy; Cisplatin; Retinoblastoma; SRPK1

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; PROTEIN KINASE; SERINE ARGININE RICH PROTEIN SPECIFIC KINASE 1; UNCLASSIFIED DRUG; VINCRISTINE;

ADOLESCENT; ADVANCED CANCER; ARTICLE; BONE MARROW METASTASIS; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STAGING; CHILD; CHOROID; DRUG EXPOSURE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINOBLASTOMA; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CISPLATIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; NEOPLASM STAGING; PROTEIN-SERINE-THREONINE KINASES; RETINAL NEOPLASMS; RETINOBLASTOMA;

EID: 37549002520     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21088     Document Type: Article

References (14)

1. Rodriguez-Galindo C, Wilson MW, Haik BG, et al. Treatment of metastatic retinoblastoma. Ophthalmology 2003;110:1237-1240.
2. Chan HS, Canton MD, Gallie BL. Chemosensitivity and multidrug resistant to antineoplastic drugs in retinoblastoma cell lines. Anticancer Res 1989;9:469-474.
3. Chan HS, Thorner PS, Haddad G, et al. Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression. Ophthalmology 1991;98:1425-1431.
4. Chan HS, Lu Y, Grogan TM, et al. Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. Cancer Res 1997;57:2325-2330.
5. Krishnakumar S, Mallikarjuna K, Desai N, et al. Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma. Br J Ophthalmol 2004;88:1521-1526.
6. Johnson SW, Ferry KV, Hamilton TC. Recent insights into platinum drug resistance in cancer. Drug Resist Updates 1998;1: 243-254.
7. Wernyj RP, Morin PJ. Molecular mechanisms of platinum resistance: Still searching for the Achilles' heel. Drug Resist Updat 2004;7:227-232.
8. Schenk PW, Boersma AW, Brandsma JA, et al. SKY1 is involved in cisplatin-induced cell kill in Saccharomyces Cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line. Cancer Res 2001;61:6982-6986.
9. Murphree AL. Intraocular retinoblastoma: The case for a new group classification. Ophthalmol Clin North Am 2005;18: 41-54.
10. Schenk PW, Stoop H, Bokemeyer C, Mayer F, Stoter G, Oosterhuis JW, Wiemer E, Looijenga LH, Nooter K. Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1. Neoplasia 2004;6:297-301.
11. Abramson DH, Lawrence SD, Beaverson KL, Lee TC, Rollins IS, Dunkel IJ. Systemic carboplatin for retinoblastoma: Change in tumour size over time. Br J Ophthalmol 2005;89:1616-1619.
12. Lee TC, Hayashi NI, Dunkel IJ, Beaverson K, Novetsky D, Abramson DH. New retinoblastoma tumor formation in children initially treated with systemic carboplatin. Ophthalmology 2003;110:1989-1994.
13. Dorrell MI, Aguilar E, Weber C, Friedlander M. Global gene expression analysis of the developing postnatal mouse retina. Invest Ophthalmol Vis Sci 2004;45:1009-1019.
14. Mohan A, Kandalam M, Ramkumar HL, Gopal L, Krishnakumar S. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma. Br J Ophthalmol 2006;90:889-893.